BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36772945)

  • 1. Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study.
    Zheng S; Liang JY; Tang Y; Xie J; Zou Y; Yang A; Shao N; Kuang X; Ji F; Liu X; Tian W; Xiao W; Lin Y
    Clin Transl Med; 2023 Feb; 13(2):e1189. PubMed ID: 36772945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdissection of cancer-associated fibroblast infiltration subtypes unveils the secreted SERPINE2 contributing to immunosuppressive microenvironment and immuotherapeutic resistance in gastric cancer: A large-scale study integrating bulk and single-cell transcriptome profiling.
    Zhang D; Sun R; Di C; Li L; Zhao F; Han Y; Zhang W
    Comput Biol Med; 2023 Nov; 166():107406. PubMed ID: 37729702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of BGN positive fibroblasts as a driving factor for colorectal cancer and development of its related prognostic model combined with machine learning.
    Hu S; Xiao Q; Gao R; Qin J; Nie J; Chen Y; Lou J; Ding M; Pan Y; Wang S
    BMC Cancer; 2024 Apr; 24(1):516. PubMed ID: 38654221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W; Wang M; Wang M; Liu M
    Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.
    Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X
    Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma.
    Zhong YJ; Luo XM; Liu F; He ZQ; Yang SQ; Ma WJ; Wang JK; Dai YS; Zou RQ; Hu YF; Lv TR; Li FY; Hu HJ
    J Transl Med; 2024 May; 22(1):422. PubMed ID: 38702814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas.
    Chen B; Chan WN; Xie F; Mui CW; Liu X; Cheung AHK; Lung RWM; Chow C; Zhang Z; Fang C; Yu P; Shi S; Zhou S; Chen G; Wang Z; Wang S; Ding X; Huang B; Liang L; Dong Y; Wong CC; Wu WKK; Cheng ASL; Wong N; Yu J; Lo KW; Tse GMK; Kang W; To KF
    Clin Transl Med; 2023 Dec; 13(12):e1516. PubMed ID: 38148640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment.
    Ma C; Yang C; Peng A; Sun T; Ji X; Mi J; Wei L; Shen S; Feng Q
    Mol Cancer; 2023 Oct; 22(1):170. PubMed ID: 37833788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockout of Shcbp1 sensitizes immunotherapy by regulating α-SMA positive cancer-associated fibroblasts.
    Gu Q; Ma Z; Wang Q; Dai Y; Shi W; Jiao Z
    Mol Carcinog; 2024 Apr; 63(4):601-616. PubMed ID: 38169303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive MFAP2
    Wei R; Song J; Liu X; Huo S; Liu C; Liu X
    Cell Oncol (Dordr); 2024 Feb; 47(1):55-68. PubMed ID: 37540308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell Transcriptomic Analysis Reveals an Immunosuppressive Network Between POSTN CAFs and ACKR1 ECs in TKI-resistant Lung Cancer.
    Wang Z; Yan N; Sheng H; Xiao Y; Sun J; Cao C
    Cancer Genomics Proteomics; 2024; 21(1):65-78. PubMed ID: 38151287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
    Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
    Gene; 2024 May; 907():148286. PubMed ID: 38367852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial and Single-Cell Transcriptomics Reveal a Cancer-Associated Fibroblast Subset in HNSCC That Restricts Infiltration and Antitumor Activity of CD8+ T Cells.
    Li C; Guo H; Zhai P; Yan M; Liu C; Wang X; Shi C; Li J; Tong T; Zhang Z; Ma H; Zhang J
    Cancer Res; 2024 Jan; 84(2):258-275. PubMed ID: 37930937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pan-cancer single-cell transcriptional analysis of antigen-presenting cancer-associated fibroblasts in the tumor microenvironment.
    Chen J; Chen R; Huang J
    Front Immunol; 2024; 15():1372432. PubMed ID: 38903527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy.
    Cong L; Maishi N; Annan DA; Young MF; Morimoto H; Morimoto M; Nam JM; Hida Y; Hida K
    Breast Cancer Res; 2021 May; 23(1):51. PubMed ID: 33966638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting tumor microenvironment heterogeneity in syngeneic mouse models: insights on cancer-associated fibroblast phenotypes shaped by infiltrating T cells.
    Carretta M; Thorseth ML; Schina A; Agardy DA; Johansen AZ; Baker KJ; Khan S; Rømer AMA; Fjæstad KY; Linder H; Kuczek DE; Donia M; Grøntved L; Madsen DH
    Front Immunol; 2023; 14():1320614. PubMed ID: 38259467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
    Zhang H; Yue X; Chen Z; Liu C; Wu W; Zhang N; Liu Z; Yang L; Jiang Q; Cheng Q; Luo P; Liu G
    Mol Cancer; 2023 Oct; 22(1):159. PubMed ID: 37784082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions.
    Jenkins BH; Buckingham JF; Hanley CJ; Thomas GJ
    Pharmacol Ther; 2022 Dec; 240():108231. PubMed ID: 35718294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies.
    Xu Y; Li W; Lin S; Liu B; Wu P; Li L
    Cell Commun Signal; 2023 Sep; 21(1):234. PubMed ID: 37723510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting cellular states of infiltrating microenvironment cells in melanoma by integrating single-cell and bulk transcriptome analysis.
    Shi A; Yan M; Pang B; Pang L; Wang Y; Lan Y; Zhang X; Xu J; Ping Y; Hu J
    BMC Immunol; 2023 Dec; 24(1):52. PubMed ID: 38082384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.